MedTrace Logo

Balance Evaluation in Adult Hemophilia

NCT07243912 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 81

Last updated 2025-11-24

No results posted yet for this study

Summary

Introduction: Recurrent hemarthrosis in hemophilia can cause deterioration of static and dynamic balance in hemophilia. Studies in AwH report decreased dynamic balance, but consistent results regarding static balance are lacking. The causes of the decrease in dynamic balance and its associated parameters have been under explored.

Aim: To investigate static and dynamic balance in AwH compared to healthy controls and factors such as joint health, physical activity and kinesiophobia that may affect dynamic balance.

Methods: This cross-sectional controlled study included 41 AwH and 40 healthy controlled, totally 81 man and study groups determined as Hemophilia Group (HG) and Control Group (CG). Static (Static Stability Test) and dynamic balance (Limits of Stability Test (LoS) Test) were assessed Pro-kin Technobody Posturographic Platform; physical activity level with International Physical Activity Questionnaire (IPAQ) for all groups. Joint health and kinesiophobia were assessed with Hemophilia Joint Health Score and Tampa Scale for Kinesiophobia (TSK) for HG, respectively. Participants' age, height and weight were questioned in both groups, as well as type and severity of hemophilia, type of treatment, and work/job status in HG.

Conditions

  • Postural Balance

Interventions

DIAGNOSTIC_TEST

Postural balance assessment

Static and dynamic balance was analyzed with the posturographic platform.

Sponsors & Collaborators

  • Ayse Merve TAT

    lead OTHER

Principal Investigators

  • Ayşe M Tat, Asst Prof · Yuzuncu Yil University

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-09-10
Primary Completion
2025-10-10
Completion
2025-10-20

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07243912 on ClinicalTrials.gov